Such stuff as dreams are made on: mediator-directed therapy in sepsis
- 1 May 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 2 (5), 391-405
- https://doi.org/10.1038/nrd1084
Abstract
Sepsis, a life-threatening disorder that arises through the body's response to infection, is the leading cause of death and disability for patients in an intensive care unit. Advances in the understanding of the complex biological processes responsible for the clinical syndrome have led to the identification of many promising new therapeutic targets, including bacterial toxins, host-derived mediators, and downstream processes such as coagulation and the endocrine response. Diverse therapies directed against these targets have shown dramatic effects in animal models; however, in humans, their impact has been frustratingly modest, and only one agent--recombinant activated protein C--has achieved regulatory approval. This review summarizes the approaches that have been evaluated in clinical trials, explores the reasons for the discordance between biological promise and clinical reality, and points to approaches that may lead to greater success in the future.Keywords
This publication has 97 references indexed in Scilit:
- The Pathophysiology and Treatment of SepsisThe New England Journal of Medicine, 2003
- A Genomic and Proteomic Analysis of Activation of the Human Neutrophil by Lipopolysaccharide and Its Mediation by p38 Mitogen-activated Protein KinaseOnline Journal of Public Health Informatics, 2002
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Effect of ibuprofen in patients with severe sepsisCritical Care Medicine, 1991
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal SubjectsThe New England Journal of Medicine, 1990
- Genetic and Environmental Influences on Premature Death in Adult AdopteesThe New England Journal of Medicine, 1988
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisThe New England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockThe New England Journal of Medicine, 1987
- The Effects of High-Dose Corticosteroids in Patients with Septic ShockThe New England Journal of Medicine, 1984
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliThe New England Journal of Medicine, 1982